These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 3777960
21. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer]. Satomi T, Inoue S, Fujita T, Ogawa S, Honda H, Hayashi M. Gan No Rinsho; 1989 Mar; 35(4):512-5. PubMed ID: 2541269 [Abstract] [Full Text] [Related]
22. [Immunotherapy of gastric cancer]. Kan N, Ohgaki K, Okino T, Nakanishi M, Nio Y, Inoue K, Tobe T. Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):755-62. PubMed ID: 3291771 [Abstract] [Full Text] [Related]
23. [Randomized controlled study of OK-432 in the treatment of cancerous pleurisy]. Urata A, Nishimura M, Ota K. Gan To Kagaku Ryoho; 1983 Jun; 10(6):1497-503. PubMed ID: 6409006 [Abstract] [Full Text] [Related]
24. [Management of malignant ascites with a streptococcal preparation, OK-432: induction of growth inhibition factor(s) against tumor cells]. Katano M, Yamamoto H, Hisatsugu T. Nihon Geka Gakkai Zasshi; 1986 Apr; 87(4):471. PubMed ID: 3713694 [No Abstract] [Full Text] [Related]
25. [Enhancing activity of bacterial preparations on blood flow in tumor tissue, with reference to cancer chemotherapy. Experimental and clinical studies]. Kudo T, Abo S, Itabashi T, Onodera K, Shikama T, Hashimoto M, Kawamura Y, Tsuji K, Watanabe K, Ikeda T. Gan To Kagaku Ryoho; 1985 Nov; 12(11):2166-71. PubMed ID: 4062317 [Abstract] [Full Text] [Related]
26. [Lymphoid infiltration of colon cancer and clinical significance of the skin test]. Usami S, Ueda O, Sato M, Kamiya Y, Okubo T, Kotani H, Yura J. Nihon Geka Gakkai Zasshi; 1992 Oct; 93(10):1305-11. PubMed ID: 1435693 [Abstract] [Full Text] [Related]
27. [Skin reaction to OK-432 and its dosage for locoregional administration]. Yamaguchi Y, Noma K, Miyahara E, Funakoshi M, Takashima I, Kawami H, Sawamura A, Toge T. Gan To Kagaku Ryoho; 1994 Sep; 21(13):2108-10. PubMed ID: 7944414 [Abstract] [Full Text] [Related]
28. Hemolytic streptococcus preparation OK-432; beneficial adjuvant therapy in recurrent gastric carcinoma. Hanaue H, Kim DY, Machimura T, Tsukui M, Kubota M, Kurosawa T, Shikata J, Kondoh Y, Ogoshi K, Makuuchi H. Tokai J Exp Clin Med; 1987 Nov; 12(4):209-14. PubMed ID: 3503390 [Abstract] [Full Text] [Related]
29. Clinical value of immunochemotherapy with OK-432 or PS-K for stomach cancer patients. Fujimoto S, Takahashi M, Minami T, Ishigami H, Miyazaki M, Itoh K. Jpn J Surg; 1979 Sep; 9(3):190-6. PubMed ID: 470251 [Abstract] [Full Text] [Related]
30. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432. Hanaue H, Nomoto S, Kimura T, Kutsuna T, Takeuchi T, Yoshizaki S. Keio J Med; 1982 Dec; 31(4):159-68. PubMed ID: 6985379 [No Abstract] [Full Text] [Related]
31. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432]. Neda H, Watanabe N, Sone H, Yamauchi N, Niitsu Y, Urushizaki I. Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382 [Abstract] [Full Text] [Related]
32. [A case of unresectable advanced gastric cancer with effective treatment by local administration of OK-432 on operation]. Kodama M, Taniguchi T, Furukawa H, Takahashi T, Hara T. Gan To Kagaku Ryoho; 1989 Jun; 16(6):2301-3. PubMed ID: 2735772 [Abstract] [Full Text] [Related]
33. [Clinical evaluation of immunochemotherapy with streptococcal preparation "OK-432" on inoperable advanced cancers (author's transl)]. Nio Y, Nitta N, Tanaka A, Ichikawa T, Henmi K. Nihon Geka Hokan; 1981 Sep 01; 50(5):704-10. PubMed ID: 7332399 [No Abstract] [Full Text] [Related]
34. [A multi-center trial of MY-1, a new biological response modifier, on the immunological parameters of postoperative gastric cancer patients]. Ochiai T, Sato H, Isono K, Uematsu T, Nakajima K, Mukai M, Asano T, Onoda S, Morioka Y, Danno M. Gan To Kagaku Ryoho; 1986 Apr 01; 13(4 Pt 1):959-69. PubMed ID: 3963860 [Abstract] [Full Text] [Related]
35. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer]. Yamane T, Sagara Y, Suzuki G, Kasuga M, Sakita M, Fujita Y, Majima S. Gan To Kagaku Ryoho; 1984 Apr 01; 11(4):930-4. PubMed ID: 6721507 [Abstract] [Full Text] [Related]
36. Effect of immunochemotherapy on lymphocyte response of patients with gastrointestinal cancer. Mashiba H, Yoshinaga H, Matsunaga K, Gojobori M, Furusawa M. J Surg Oncol; 1979 Apr 01; 12(3):275-9. PubMed ID: 502567 [Abstract] [Full Text] [Related]
37. [Influence of OK 432 upon postoperative alteration in activities producing lymphokines, IL 1, IL 2, and IFN, of peripheral blood mononuclear cells derived from patients with gastric cancer]. Hosoi J. Nihon Gan Chiryo Gakkai Shi; 1987 Apr 20; 22(3):603-13. PubMed ID: 2443588 [No Abstract] [Full Text] [Related]
38. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment. Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T. Int J Oncol; 2004 Apr 20; 24(4):959-66. PubMed ID: 15010836 [Abstract] [Full Text] [Related]
40. [Immunological examination in patients with brain tumor and the usefulness of PHA skin test (author's transl)]. Imagawa K, Tochio H, Toda I, Hayashi M, Asai A, Nomura T, Miyaji H. No To Shinkei; 1978 Nov 20; 30(11):1171-6. PubMed ID: 728272 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]